CCR5 pathway candidate genes susceptible to HIV-infection.

被引:0
|
作者
Shrestha, S
Strathdee, SA
Galai, N
Thomas, D
Vlahov, D
O'Brien, SJ
Smith, MW
机构
[1] NCI, Basic Res Program, Frederick, MD 21701 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA
[4] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[5] NCI, Lab Genomic Divers, NIH, Frederick, MD 21701 USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
1259
引用
收藏
页码:385 / 385
页数:1
相关论文
共 50 条
  • [31] HIV-1 infection in an individual homozygous for CCR5 Delta 32
    Theodorou, I
    Meyer, L
    Magierowska, M
    Katlama, C
    Rouzioux, C
    LANCET, 1997, 349 (9060): : 1219 - 1220
  • [32] HIV-1 infection in an individual homozygous for the CCR5 deletion allele
    Biti, R
    French, RF
    Young, J
    Bennetts, B
    Stewart, G
    Liang, T
    NATURE MEDICINE, 1997, 3 (03) : 252 - 253
  • [33] Cenicriviroc, an orally active CCR5 antagonist for the potential treatment of HIV infection
    Klibanov, Olga M.
    Williams, Shannon H.
    Iler, Cameron A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (08) : 940 - 950
  • [34] Intestinal mucosal CCR5 expression is down-regulated in HIV infection
    McGowan, I
    Elliott, J
    Taing, P
    Fuerst, M
    Boscardin, J
    Anton, P
    GASTROENTEROLOGY, 2003, 124 (04) : A155 - A155
  • [35] HIV-1 infection in a man homozygous for CCR5 Delta 32
    OBrien, TR
    Winkler, C
    Dean, M
    Nelson, JAE
    Carrington, M
    Michael, NL
    White, GC
    LANCET, 1997, 349 (9060): : 1219 - 1219
  • [36] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
    He, JL
    Chen, YZ
    Farzan, M
    Choe, HY
    Ohagen, A
    Gartner, S
    Busciglio, J
    Yang, XY
    Hofmann, W
    Newman, W
    Mackay, CR
    Sodroski, J
    Gabuzda, D
    NATURE, 1997, 385 (6617) : 645 - 649
  • [37] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
    Jianglin He
    Youzhi Chen
    Michael Farzan
    Hyeryun Choe
    Asa Ohagen
    Suzanne Gartner
    Jorge Busciglio
    Xiaoyu Yang
    Wolfgang Hofmann
    Walter Newman
    Charles R. Mackay
    Joseph Sodroski
    Dana Gabuzda
    Nature, 1997, 385 : 645 - 649
  • [38] Effects of CCR2 and CCR5 polymorphisms on HIV-1 infection in Thai females
    Wichukchinda, Nuanjun
    Nakayama, Emi E.
    Rojanawiwat, Archawin
    Pathipvanich, Panita
    Auwanit, Rattana
    Vongsheree, Suthon
    Ariyoshi, Koya
    Sawanpanyalert, Pathom
    Shioda, Tatsuo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (03) : 293 - 297
  • [39] Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization
    Anderson, Joseph S.
    Walker, Jon
    Nolta, Jan A.
    Bauer, Gerhard
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (02) : 152 - 161
  • [40] CRISPR in HIV: dangers of CCR5 deletion
    Rusconi, Stefano
    Giacomelli, Andrea
    FUTURE VIROLOGY, 2020, 15 (04) : 207 - 210